Abstract
Traditional Chinese medicines (TCM) have recently been recognized as a new source of anticancer drugs and new chemotherapy adjuvant to enhance the efficacy of chemotherapy and to diminish side effects and resistance of cancer chemotherapies. At the same time, cisplatin, one of the most widely used anticancer drugs, is effective in treating a variety of cancers, especially testicular cancer for which it has a greater than 90% cure rate, but its clinical efficacy is limited by significant side effects and acquired or intrinsic resistance. Therefore, many efforts have been devoted to designing new platinum compounds with improved pharmacological properties and a broader range of antitumour activity. New strategies have been applied in the designs of antitumour coordination compounds as drugs, such as synthesizing new ligands or metal complexes with different reaction mechanisms. Among them, new coordination compounds based on traditional Chinese medicines (TCMs) provide a novel approach to potential (pro-)drugs. This review mainly focuses on the synthesis, structure, antitumour activity and interactions with molecular targets of TCM based metal complexes. TCM alkaloids, flavonoids, cantharidin, coumarins, plumbagin, curcumin and camphoric acid metal-based antitumour agents are covered. The future development of hybrid TCM-metal complexes as antitumour drugs is discussed. The pursuit of new TCM metal-based anticancer drugs and enhancement of modern TCM holds promise for overcoming multidrug resistance (MDR).
Keywords: Antitumour agents, metal complexes, traditional Chinese medicine (TCM)
Anti-Cancer Agents in Medicinal Chemistry
Title: Progresses in TCM Metal-Based Antitumour Agents
Volume: 10 Issue: 5
Author(s): Zhen-Feng Chen and Hong Liang
Affiliation:
Keywords: Antitumour agents, metal complexes, traditional Chinese medicine (TCM)
Abstract: Traditional Chinese medicines (TCM) have recently been recognized as a new source of anticancer drugs and new chemotherapy adjuvant to enhance the efficacy of chemotherapy and to diminish side effects and resistance of cancer chemotherapies. At the same time, cisplatin, one of the most widely used anticancer drugs, is effective in treating a variety of cancers, especially testicular cancer for which it has a greater than 90% cure rate, but its clinical efficacy is limited by significant side effects and acquired or intrinsic resistance. Therefore, many efforts have been devoted to designing new platinum compounds with improved pharmacological properties and a broader range of antitumour activity. New strategies have been applied in the designs of antitumour coordination compounds as drugs, such as synthesizing new ligands or metal complexes with different reaction mechanisms. Among them, new coordination compounds based on traditional Chinese medicines (TCMs) provide a novel approach to potential (pro-)drugs. This review mainly focuses on the synthesis, structure, antitumour activity and interactions with molecular targets of TCM based metal complexes. TCM alkaloids, flavonoids, cantharidin, coumarins, plumbagin, curcumin and camphoric acid metal-based antitumour agents are covered. The future development of hybrid TCM-metal complexes as antitumour drugs is discussed. The pursuit of new TCM metal-based anticancer drugs and enhancement of modern TCM holds promise for overcoming multidrug resistance (MDR).
Export Options
About this article
Cite this article as:
Chen Zhen-Feng and Liang Hong, Progresses in TCM Metal-Based Antitumour Agents, Anti-Cancer Agents in Medicinal Chemistry 2010; 10 (5) . https://dx.doi.org/10.2174/1871520611009050412
DOI https://dx.doi.org/10.2174/1871520611009050412 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
Call for Papers in Thematic Issues
Induction of cell death in cancer cells by modulating telomerase activity using small molecule drugs
Telomeres are distinctive but short stretches present at the corners of chromosomes and aid in stabilizing chromosomal makeup. Resynthesis of telomeres supported by the activity of reverse transcriptase ribonucleoprotein complex telomerase. There is no any telomerase activity in human somatic cells, but the stem cells and germ cells undergone telomerase ...read more
Role of natural compounds as anti anti-cancer agents
Cancer is considered the leading cause of worldwide mortality, accounting for nearly 10 million deaths in 2022. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy remains an important approach in treatment o f several types of cancers, even though ...read more
Signaling and enzymatic modulators in cancer treatment
Cancer accounts for nearly 10 million deaths in 2022 and is considered the leading cause of worldwide mortality. Cancer outcome can be improved through an appropriate screening and early detection and through an efficient clinical treatment. Chemotherapy, radiotherapy and surgery are the most important approach for the treatment of several ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cancer Multitarget Pharmacology in Prostate Tumors: Tyrosine Kinase Inhibitors and Beyond
Current Medicinal Chemistry Cross-Talk between Oxidative Stress and Pro-Inflammatory Cytokines in Acute Pancreatitis: A Key Role for Protein Phosphatases
Current Pharmaceutical Design Natural Products As Antimitotic Agents
Current Topics in Medicinal Chemistry Estrone (E1) Based Esters as Potential Inhibitors of Type 3 17β- hydroxysteroid Dehydrogenase (17β-HSD3) in the Treatment of Hormone-Dependent Prostate Cancer
Letters in Drug Design & Discovery Structure, Roles and Inhibitors of a Mitotic Protein Kinase Haspin
Current Medicinal Chemistry Expression and Characterisation of Recombinant Molecules in Transgenic Soybean
Current Pharmaceutical Design High-Intensity Focused Ultrasound in the Treatment of Breast Cancer
Current Medicinal Chemistry Vascular Endothelial Growth Factor and Its Receptor as Drug Targets in Hematological Malignancies
Current Drug Targets Antineoplastic Activities, Apoptotic Mechanism of Action and Structural Properties of a Novel Silver(I) Chelate
Current Medicinal Chemistry High Throughput Screening for Colorectal Cancer Specific Compounds
Combinatorial Chemistry & High Throughput Screening Role of Retinoids, Rexinoids and Thyroid Hormone in the Expression of Cytochrome P450 Enzymes
Current Drug Metabolism Membrane Fusion Mediated Targeted Cytosolic Drug Delivery Through scFv Engineered Sendai Viral Envelopes
Current Molecular Medicine “The Future Magic Bullet”: A Review of Pharmacological Activities of Ethyl Pyruvate and its Derivatives
Current Drug Therapy Angiogenesis and Angiogenesis Inhibitors: a New Potential Anticancer Therapeutic Strategy
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Practical Aspects in the Use of Biomarkers for the Development of Cancer Vaccines
Current Cancer Therapy Reviews Herbal Resources to Combat a Progressive & Degenerative Nervous System Disorder- Parkinson’s Disease
Current Drug Targets Transcriptional and Post-Transcriptional Regulations of Junction Proteins in Mammalian estes – Implications on Male Contraceptive Development
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Neurological Involvement in Rheumatoid Arthritis
Current Immunology Reviews (Discontinued) MicroRNAs in Tumorigenesis
Current Pharmaceutical Biotechnology Creating A Standard of Care for Fertility Preservation
Current Women`s Health Reviews